Short interest in TransCode Therapeutics Inc (NASDAQ:RNAZ) decreased during the last reporting period, falling from 1.22M to 743.58K. This put 4.31% of the company's publicly available shares short.

Short interest for TransCode Therapeutics gives investors a sense of the degree to which investors are betting on the decline of TransCode Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 785.24K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.